Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03869216 · ClinicalTrials.gov registry record · NA

Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American Men

A NA study of Prostate Cancer, sponsored by Xavier University of Louisiana..

Completed
Registry status
NA
Development phase
161
Enrollment target
1
Study location

NCT03869216 is a NA study of Prostate Cancer that has completed, run by Xavier University of Louisiana.. The registered enrollment target is 161 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03869216, a NA study of Prostate Cancer, has completed, sponsored by Xavier University of Louisiana..

COMPLETED
Registry status
NA
Development phase
161 participants
Enrollment target
1
Study location

Study Summary

This behavioral clinical trial assesses the efficacy of a educational intervention to increase shared decision making about prostate-specific antigen (PSA)-based screening for prostate cancer among African American males. Half of participants will receive a multimedia educational intervention, while the other half will receive usual care.

Conditions Studied

Interventions

  • BEHAVIORAL Educational Shared Decision-Making Intervention

Study Locations (1)

Louisiana

  • Tulane Medical Center - New Orleans

Trial Details

FieldValue
Enrollment Target 161 participants
Start Date 2020-08-17
Est. Completion 2023-12-31
Phase NA

Sponsor

Xavier University of Louisiana.

6 total trials

What the Registry Record Tells You About NCT03869216

The ClinicalTrials.gov registry entry for NCT03869216 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (74% lower). The listed sponsor is Xavier University of Louisiana., which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Educational Shared Decision-Making Intervention is the first listed.

NCT03869216 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT03869216 about?

NCT03869216 is a clinical study titled "Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American Men". This behavioral clinical trial assesses the efficacy of a educational intervention to increase shared decision making about prostate-specific antigen (PSA)-based screening for prostate cancer among African American males. Half of participants will receive a multimedia educational intervention, while...

What is the current status of trial NCT03869216?

This trial is currently completed. It is a NA study. The enrollment target is 161 participants. The study started on 2020-08-17. Estimated completion is 2023-12-31.

What conditions does trial NCT03869216 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT03869216?

The interventions under investigation include: Educational Shared Decision-Making Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03869216?

This trial is sponsored by Xavier University of Louisiana., which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03869216 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.